Complications of Transarterial Chemoembolization (TACE) in the Treatment of Liver Tumors
| Autor: | Alejandro Manrique Municio, Ricardo San Román Manso, Álvaro García-Sesma, Alberto Marcacuzco Quinto, Iago Justo Alonso, Oana-Anisa Nutu, Luis Carlos Jiménez Romero, Javier Martínez Caballero, Carmelo Loinaz Segurola, Jorge Calvo Pulido |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Male
medicine.medical_specialty Liver tumor Gastroenterology 03 medical and health sciences Hepatic Artery 0302 clinical medicine Internal medicine Ascites medicine Humans Decompensation Chemoembolization Therapeutic Aged Retrospective Studies business.industry Bile duct Liver Neoplasms General Engineering Middle Aged medicine.disease Pulmonary embolism medicine.anatomical_structure 030220 oncology & carcinogenesis Hepatocellular carcinoma Acute pancreatitis Female 030211 gastroenterology & hepatology medicine.symptom business Liver abscess |
| Zdroj: | Cirugía Española (English Edition). 96:560-567 |
| ISSN: | 2173-5077 |
| Popis: | Introduction Transarterial chemoembolization (TACE) is considered a therapeutic option. It is mostly used in hepatocellular carcinoma or liver colorectal, neuroendocrine or melanoma metastases. Although it is considered a safe procedure, TACE presents complications, such as acute cholecystitis, which is the most common. Other procedure-related complications include pulmonary embolism, hepatic abscess, bile duct injury, gastric mucosa injury and, less frequently, acute pancreatitis. The aim of this study is to review the complications following TACE for liver tumors. Methods We performed a retrospective study including all the TACE procedures performed in a single center during the period between January 2013 and December 2016. Results Out of the 196 patients with liver tumors who had undergone 322 TACE, 258 (80%) were male and 64 (20%) were female. Mean patient age was 66.5 years. Major complications after chemoembolization included: decompensation with edema/ascites (6 patients), acute cholecystitis (4), acute pancreatitis (3), liver rupture (1), liver abscess (1) and renal failure (1). Postembolization syndrome appeared in 71 (20%) patients. On multivariate analysis, it was observed that concomitant cardiovascular disease (OR: 4.5; 95% CI: 1.2–17; P=.025) is a risk factor for the development of complications. Conclusions TACE is a safe and effective procedure for liver tumor treatment. The majority of the complications are rare and present a low incidence of mortality. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect